Concepedia

Author

Michał Gniot

Poznan University of Medical SciencesORCID

Also Known As

A Aggerholm, Gniot Michał, Gniot, Michał, M Gniot, M. Gniot, Michal Gniot, Michał Gniot

47

Publications

310

Citations

10

H-Index

12

Concepts

All Affiliations

Poznan University of Medical SciencesZealand University HospitalG. Papanikolaou General HospitalUniversity of SouthamptonNational Specialized Hospital for Active Treatment of Hematologic Diseases
MG

About

Michał Gniot is an author at Poznan University of Medical Sciences specializing in hematology, pathology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

36

2

Medicine

2

2

36

3

Pathology

2

2

36

4

Cell Biology

1

1

12

5

Immunology

1

1

24

Michał Gniot

×

9

Publications

239

Citations

9

H-Index

YearCitations

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

Nicholas C.P. Cross, Helen White, Thomas Ernst,

Leukemia

2016

58

Variant‐specific discrepancy when quantitating <i>BCR‐ABL1</i> e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay

Vibe Skov, Morten Andersen, Anni Aggerholm,

European Journal Of Haematology

2019

40

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study

Helen White, Matthew Salmon, Francesco Albano,

Leukemia

2022

34

Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation

Maciej Kaźmierczak, Magdalena Łuczak, Krzysztof Lewandowski,

Medical Oncology

2013

25

Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene

Marta Barańska, Krzysztof Lewandowski, Michał Gniot,

Journal of Applied Genetics

2008

24

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome

Agnieszka Piekarska, Lidia Gil, Witold Prejzner,

Annals of Hematology

2015

18

Frequency of BCR‑ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib. A final report of the MAPTEST study

Krzysztof Lewandowski, Krzysztof Warzocha, Andrzej Hellmann,

Polskie Archiwum Medycyny Wewnętrznej

2009

16

Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia

Ewa Wasilewska, Barbara Panasiuk, Michał Gniot,

Cancer Genetics

2017

12

Coexistence of <i>JAK2</i> or <i>CALR</i> mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Krzysztof Lewandowski, Michał Gniot, Marzena Wojtaszewska,

International Journal of Laboratory Hematology

2018

12

Page 1